share_log

龙津药业:董事会审计委员会对会计师事务所2023年度履职情况评估总结报告

Kunming Longjin Pharmaceutical: Summary report of the Board Audit Committee on the evaluation of the accounting firm's performance in 2023

Sensex a share ·  May 5
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more